APA (7th ed.) Citation

Mittelbronn, M., Capper, D., Bunz, B., Dietz, K., Goeppert, B., Ajaaj, R., . . . Simon, P. (2007). De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathology & Applied Neurobiology, 33(3), 299. https://doi.org/10.1111/j.1365-2990.2006.00820.x

Chicago Style (17th ed.) Citation

Mittelbronn, M., et al. "De Novo Erythropoietin Receptor (EPO-R) Expression in Human Neoplastic Glial Cells Decreases with Grade of Malignancy but Is Favourably Associated with Patient Survival." Neuropathology & Applied Neurobiology 33, no. 3 (2007): 299. https://doi.org/10.1111/j.1365-2990.2006.00820.x.

MLA (9th ed.) Citation

Mittelbronn, M., et al. "De Novo Erythropoietin Receptor (EPO-R) Expression in Human Neoplastic Glial Cells Decreases with Grade of Malignancy but Is Favourably Associated with Patient Survival." Neuropathology & Applied Neurobiology, vol. 33, no. 3, 2007, p. 299, https://doi.org/10.1111/j.1365-2990.2006.00820.x.